Regen Med. 2008 Jul;3(4):531-46.

Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.

Source

EA 1638: Hematologie, Faculté de médicine Saint Antoine, UPMC, Paris 6, France. nasef@doctor.com

Abstract

Co-transplantation of mesenchymal stem cells (MSCs) and hematopoietic stem cells ameliorate hematopoietic reconstitution and induce tolerance. The immunomodulatory properties of MSCs have been demonstrated both in vivo and in vitro. MSCs can modulate function of immune cells such as T lymphocytes, antigen-presenting cells and natural killer cells. However, it is unknown whether MSCs given to patients that have undergone HSC transplantation could alleviate graft versus leukemia effect or could increase the risk of the infection. Proper characterization of MSC immunomodulatory mechanisms are crucial to anticipate the possible effect of MSC in the host. In the current report, interesting and contradictory results in the literature are reviewed in an attempt to understand the underlying mechanism. Differences in experimental designs and models used seem to be the underlying causes of discrepancy in reported results. Results of the few in vivo studies are controversial and further clinical studies are needed to confirm the efficiency and safety of MSCs in transplantation management.

PMID:: 18588475; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Immunomodulatory properties of mesenchymal stromal cells. [Blood. 2007]
Review Immunomodulatory properties of mesenchymal stromal cells.
Nauta AJ, Fibbe WE. Blood. 2007 Nov 15; 110(10):3499-506. Epub 2007 Jul 30.
Review Multipotent mesenchymal stromal cells and immune tolerance. [Leuk Lymphoma. 2007]
Review Multipotent mesenchymal stromal cells and immune tolerance.
Noël D, Djouad F, Bouffi C, Mrugala D, Jorgensen C. Leuk Lymphoma. 2007 Jul; 48(7):1283-9.
Review [Immunomodulation of bone marrow mesenchymal stem cells in hematopoietic stem cell transplantation--review]. [Zhongguo Shi Yan Xue Ye Xue Za...]
Review [Immunomodulation of bone marrow mesenchymal stem cells in hematopoietic stem cell transplantation--review].
Gao L, Wang JM. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Oct; 13(5):907-10.
Review Immune properties of mesenchymal stem cells. [Methods Mol Biol. 2007]
Review Immune properties of mesenchymal stem cells.
Sotiropoulou PA, Papamichail M. Methods Mol Biol. 2007; 407:225-43.
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. [Blood Cells Mol Dis. 2008]
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.
Müller I, Kordowich S, Holzwarth C, Isensee G, Lang P, Neunhoeffer F, Dominici M, Greil J, Handgretinger R. Blood Cells Mol Dis. 2008 Jan-Feb; 40(1):25-32. Epub 2007 Sep 14.

See reviews... See all...

Cited by 12 PubMed Central articles

Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase. [Front Immunol. 2012]
Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase.
Zinöcker S, Vaage JT. Front Immunol. 2012; 3:62. Epub 2012 Apr 2.
Risk factors in the development of stem cell therapy. [J Transl Med. 2011]
Risk factors in the development of stem cell therapy.
Herberts CA, Kwa MS, Hermsen HP. J Transl Med. 2011 Mar 22; 9:29. Epub 2011 Mar 22.
The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. [Immunology. 2011]
The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice.
Zhou Y, Yuan J, Zhou B, Lee AJ, Lee AJ, Ghawji M Jr, Yoo TJ. Immunology. 2011 May; 133(1):133-40. Epub 2011 Mar 2.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms.
Regen Med. 2008 Jul ;3(4):531-46.

PubMed
Bortezomib in the front-line treatment of multiple myeloma.
Bortezomib in the front-line treatment of multiple myeloma.
Expert Rev Anticancer Ther. 2008 Jul ;8(7):1053-72.

PubMed
Health literacy not race predicts end-of-life care preferences.
Health literacy not race predicts end-of-life care preferences.
J Palliat Med. 2008 Jun ;11(5):754-62.

PubMed
Explanatory model of help-seeking and coping mechanisms among depressed women in...
Explanatory model of help-seeking and coping mechanisms among depressed women in three ethnic groups of Fars, Kurdish, and Turkish in Iran.
Arch Iran Med. 2008 Jul ;11(4):397-406.

PubMed
Clinical correlates of patients with rapid-cycling bipolar disorder and a recent...
Clinical correlates of patients with rapid-cycling bipolar disorder and a recent history of substance use disorder: a subtype comparison from baseline data of 2 randomized, placebo-controlled trials.
J Clin Psychiatry. 2008 Jul ;69(7):1057-63.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: